1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
Can You Come for a Visit? My ME/CFS Says No
My daughter and son-in-law just had a baby last week. We are thrilled. But we won't be able to see the baby or hold her any time soon. We won't be able to take over little gifts or help out with housework or babysitting.
Discuss the article on the Forums.

Ampligen On the Clock: Hemispherx's 'Complete Response' Means Ball is Now in FDA's Court Now

Discussion in 'Phoenix Rising Articles' started by Phoenix Rising Team, Aug 2, 2012.

  1. satoshikasumi

    satoshikasumi Senior Member

    Messages:
    113
    Likes:
    122
    Hope123 says: "Overall, I think there will be better drugs than Ampligen, safety and efficacy-wise, in the near future and I would caution people to not push for a "political victory" without regard to safety."

    I am frankly astonished by how skeptical some in the patient community are about Ampligen and how optimistic they are that something better will be invented in the "near" future.

    I'd like to remind you that many of us have been ill 20 years or longer, and have heard the line that a treatment is just a few years away many times before. CFS is extremely difficult to treat and there are no known molecular targets. Drug companies are afraid to start. As of now, no drug company other than Hemispherx has a novel candidate drug even in phase I or II for CFS. When a target is identified, it will take five to ten years to go through the full clinical trials process. If Ampligen doesn't get approved and you are 20 years old and are disabled by CFS, that means you may be in your 30s before "something better" comes along.

    The "near" future in scientific terms really means a long, long time in real human life terms.

    And that something else may not be better. There is the idea of repurposing existing drugs like rituxan, but it is well known that rituxan can cause death. Existing antivirals carry the risk of organ damage, infertility, and death if they are not carefully monitored.

    Ampligen should have been approved for CFS back in 1998, if not earlier. There was strong evidence then that it improved all the symptoms of the condition in the majority of treated patients with severe disability and as far as we know it is safer than any other known immunomodulator.
    vli, SOC and Tally like this.
  2. Firestormm

    Firestormm Guest

    Messages:
    5,824
    Likes:
    5,969
    Cornwall England
    How can a doctor be prescribing a drug that is not FDA approved to patients for 10 years? Have I missed something only I thought Peterson was doing so in trials only, but regardless I would like to understand more about how such a thing could happen. Isn't the whole point of Ampligen trying so hard to gain this approval that they can then be offered to one and all legitimately? If Ampligen can be prescribed now, then what's the point? Sorry. I'm not familiar really with the way this works in the USA.
  3. Firestormm

    Firestormm Guest

    Messages:
    5,824
    Likes:
    5,969
    Cornwall England
    Morning Sato,

    Speaking personally and as someone having had this diagnosis now for 15 years, my scepticism is as a result of having this condition for 15 years.

    I have grown used to false starts, false promises, false hope, and therefore I'll believe it when I see it/can try it myself once it has been approved.

    Absolutely nothing wrong with scepticism but, don't get me wrong, I am at one level quite delighted to hear of any drug being manufactured specifically for my use - but Ampligen wasn't not originally.

    If it works, it works, if it doesn't well I won't have lost any more sleep about another failed promise of help.

    Generally, I am very very cautious about any drug that claims it can help such a diverse patient group even one that employs the 'best' criteria currently known.

    That said and like I mentioned above, if it does find it's way into my doctor's list of approved thing to try, I shall most definitely take it for a work-out and myself too if the claims hold up.
  4. Doogle

    Doogle Senior Member

    Messages:
    196
    Likes:
    28
    No. Hemispherix does not/never made Immunovir to my knowledge. Immunovir was developed and produced by Newport Pharmaceuticals Limited and their subsidiaries. http://www.rivexpharma.com/products_imunovir.html
  5. Snow Leopard

    Snow Leopard Senior Member

    Messages:
    2,266
    Likes:
    1,675
    Australia
    Here is hoping for ‘accelerated approval’ status!
  6. Doogle

    Doogle Senior Member

    Messages:
    196
    Likes:
    28
    Ampligen has been used in the US for over 20 years outside of FDA approved double blind studies under Investigational New Drug (IND) status. "Treatment IND is submitted for experimental drugs showing promise in clinical testing for serious or immediately life-threatening conditions while the final clinical work is conducted and the FDA review takes place." http://www.fda.gov/drugs/developmen...estigationalnewdrugindapplication/default.htm

    The length of time this has occurred is rather unique as far as I know, and is due to the political problems with the illness and Hemispherix. The FDA has not wanted to shut down access to the only drug that has ever shown promise for treating ME/CFS. Yet the FDA doesn't want to approve it for general marketing until they conclusively know the benefits of the drug clearly outweigh the risks.

    A treatment IND only allows a limited number of people to be on the drug. I believe the treatment IND Hemispherix has from the FDA allows 100 persons. The sites giving the drug have to go though a lengthy approval process and theoretically the drug company can only recoup their cost of manufacturing the drug. Right now it costs approximately $15,000 per year for the maximum dose, 400mg. IV infusion costs are extra. Most Insurance will not pay for a drug given under a treatment IND because it's still classified as experimental.

    So there are severe limitations for use of the drug under the present process hence the necessity to get full marketing approval.
    a2mandel and Firestormm like this.
  7. jimells

    jimells Senior Member

    Messages:
    374
    Likes:
    476
    northern Maine
    Like satoshikasumi, I can't wait another sixteen years, or six years, or maybe even another six months for a real treatment. How many of us will be dead from this illness by the time the FDA gets off its ass and makes a decision?

    My life has already been destroyed. If a treatment killed me quickly, that would be an improvement over dying a little each day. Right now my bank account and my ability to perform activities of daily living are in a race towards zero. My only income is food stamps, and the ground is rising up to meet me at a terrifying speed. Since I live in the US, there is no safety net and I have no parachute. But we have 'freedom': we're free to starve under a bridge, except the cops will run us off, since it is still a crime to be penniless in public!

    My application for Social Security disability is celebrating its fifth anniversary. It's now old enough to enter school, except public education is also being wrecked. No one can tell me when I will get scheduled for an ALJ hearing. If I manage to live long enough to get a hearing, the chances of winning my claim are not good.

    Meanwhile Governor 'Bully' LePage never misses an opportunity to insult and attack Mainers with no money. His latest plan is to 'reduce energy costs' by getting rid of the tiny fee on electric bills that funds a program to help poor people with their electric bills. Last year that program paid all of $120 to my account. An undeserved bonus for sure!!
    vli and Tally like this.
  8. satoshikasumi

    satoshikasumi Senior Member

    Messages:
    113
    Likes:
    122
    I know I am being somewhat of a bulldog for Ampligen. But I am one of only about a hundred patients who has actually taken Ampligen during the past five years. We, the privileged few, know that this drug is unique. It gave me back my mind. My cognitive function.

    The FDA knew Ampligen could dramatically reduce the severe debilitation associated with CFS back in 1998, when the phase II results were released. They chose not to fast track the drug for approval, in spite of the fact that these desperate patients had no other hope. At the time FDA made this decision, CDC and NIH officials publicly expressed skepticism about whether CFS was a real disease, and the view that it was a psychological or imaginary ailment was held by many doctors and government officials.

    Up until just a couple years ago, the CDC website had a detailed statement advising doctors not to order tests that could document CFS patients' disability. They said not to order tests for herpesvirus infections, not to do immune panels, not to look at natural killer cell function, not to do tilt-table tests, not to do brain function tests, claiming that none of these things had any value in diagnosing or treating CFS.

    But, the treatment section of the CDC site did and still does list psychotherapy: cognitive behavior therapy, and graded exercise therapy as the first treatments to be tried. Ask patients in the UK and EU countries how well that approach is working for them.

    In the 14 years since, no other drug company has dared to even try to develop a drug for CFS, in spite of the fact that the profit potential is huge. With Ampligen, the FDA has repeatedly sent Hemispherx on fishing expeditions to try to find something wrong with the drug- a new rodent carcinogenicity study, a new evaluation of cytokines to look for evidence that the drug induces autoimmunity. Each test looking for the ghastly side effect comes up empty-handed. Ampligen has been used in humans with CFS for more than 20 years, and some individual patients have taken it for 10 years or more of their lives because nothing else works. No one has died from Ampligen.
  9. justinreilly

    justinreilly Stop the IoM & P2P! Adopt CCC!

    Messages:
    2,490
    Likes:
    1,169
    NYC (& RI)
    Thanks for the info guys!
  10. justinreilly

    justinreilly Stop the IoM & P2P! Adopt CCC!

    Messages:
    2,490
    Likes:
    1,169
    NYC (& RI)
    Thanks for the info guys!
  11. SpecialK82

    SpecialK82 Senior Member

    Messages:
    885
    Likes:
    464
    USA
    My heart goes out to you jimells, your post has really touched me. I am glad that you are here sharing your frustration and pain with us, I hope that we can give you some comfort. Know that you are loved.
    CJB likes this.
  12. Bob

    Bob

    Messages:
    7,981
    Likes:
    10,007
    England, UK
    via @TomKindlon

  13. WillowJ

    WillowJ Senior Member

    Messages:
    2,991
    Likes:
    2,483
    WA, USA
    if approved by the FDA, any doctor would be free to prescribe Ampligen for any condition (off-label prescription is perfectly legal in USA).

    Insurance coverage in the USA would work like this: most companies have a formulary listing covered drugs. There's probably a requirement that they have a comprehensive listing (and it would be to their benefit to do so, anyway), so it would be difficult for them not to include a drug for a condition which has no other approved treatments.
    However, if they do not cover brand-name drugs on a specific plan, they might not have to cover it until there is a generic version (though it's possible they could make an exception; some insurances will do this but that's more likely if one has group insurance through someone's work).
    Your doctor still needs to convince the insurer that the treatment is 'medically necessary' for you specifically (whether because you have a diagnosis it treats, or for some other reason).

    In other countries such as Australia, the drug may have to be approved for a specific condition in order for insurance to cover.
  14. Firestormm

    Firestormm Guest

    Messages:
    5,824
    Likes:
    5,969
    Cornwall England
    Well at least it affords more insight into the clinical application of this drug and it's cost etc.
    Bob likes this.
  15. Firestormm

    Firestormm Guest

    Messages:
    5,824
    Likes:
    5,969
    Cornwall England
    So the FDA have accepted the submission from Hemispherex. Share price was up 10% on the news it seems - or it was - remains 3 cents off it's 52 week high of 51 cents but if approved then.... who knows? Fancy a punt anyone?

    http://www.virtual-strategy.com/2012/08/14/fda-accepts-complete-response-submission-regarding-ampligenr-new-drug-application-chronic
  16. alex3619

    alex3619 Senior Member

    Messages:
    7,065
    Likes:
    10,909
    Logan, Queensland, Australia
    I agree we should have had Ampligen decades ago. It could have now become generic and hence cheaper. The delay in approval has robbed two generations of patients of a chance at some recovery, and will rob another two generations who do not have the cash to pay for it once it goes commercial.

    However Rituximab is not particularly dangerous (especially if it can cure rather than treat), though not particularly safe either:

    http://arthritis-research.com/content/pdf/ar3337.pdf

    The death rate is about 3%. Much of that is from infections. Some of it is from a severe infusion reaction. However we have yet to see either in CFS or ME patients, unless I missed an announcement. We are a different patient set. On the other hand, so far not enough patients have been studied to reliably show even a 3% death rate. On the third hand, for any Moties fans out there, drugs have been withdrawn from market for death rates lower than this.

    Bye, Alex
    justinreilly likes this.
  17. Tally

    Tally Senior Member

    Messages:
    154
    Likes:
    115
    They mention that patients with depressed natural killer cell cytotoxicity have better chances of responding to Ampligen. Is this lower number of natural killer cells, or is it a different thing?
  18. Bob

    Bob

    Messages:
    7,981
    Likes:
    10,007
    England, UK
    It's almost the same thing, Tally, but "depressed natural killer cell cytotoxicity" specifically means low function, rather than low numbers. But I suppose that low function can be caused by low numbers.
    Tally likes this.
  19. Bob

    Bob

    Messages:
    7,981
    Likes:
    10,007
    England, UK
    Here's some info about the effectiveness of Ampligen.

    A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
    David R. Strayer et al
    March 14, 2012
    PLoS ONE 7(3): e31334. doi:10.1371/journal.pone.0031334
    http://www.plosone.org/article/info:doi/10.1371/journal.pone.0031334



    And here is a helpful summary:

    ME Research UK - Breakthrough Magazine:
    Autumn 2012 issue, page 12, third column, under 'Maryland':
    http://www.meresearch.org.uk/information/breakthrough/index.html

    Rintatolimod trial
    Clinical trials of non-psychological treatments
    are quite rare in ME/CFS, so it can be
    exciting when one comes along, particularly
    if the most severely affected patients
    are included. One recent example was
    a phase III randomised trial in which the
    TLR-3 agonist rintatolimod was compared
    with placebo in 234 people suffering
    with long-standing, debilitating ME/CFS
    at 12 different centres across the USA.
    After 40 weeks, exercise tolerance (total
    achievable exercise time on a treadmill) was
    significantly improved in the patients on
    intravenous rintatolimod therapy (400 mg
    twice weekly) compared with those on
    placebo. The size of the improvement was
    around 20%, equating to approximately
    68 seconds of additional treadmill activity.
    Indeed, the authors say that this level of
    improvement represents approximately twice
    the minimum considered medically significant
    by regulatory agencies. Rintatolimod also
    reduced dependence on symptom-relieving
    drugs compared with placebo, and it seems
    to have been well-tolerated with no serious
    adverse effects definitely related to the drug.
    Under its more common name, Ampligen,
    rintatolimod has been well-known to ME/
    CFS patients since the first preliminary report
    of its potential usefulness in 1994. Ampligen
    has known antiviral and immunomodulatory
    properties, and these positive results
    suggest that it may become part of the
    therapeutic armoury of treatments for ME/
    CFS, providing FDA approval is finally granted.
  20. Nielk

    Nielk

    Messages:
    5,193
    Likes:
    4,980
    Queens, NY
    Tell the FDA what your experience with Ampligen has been.

    http://www.cfscentral.com/2012/09/what-have-your-experiences-been-on.html?spref=fb

    TUESDAY, SEPTEMBER 25, 2012





    The Food and Drug Administration (FDA) will once again decide this winter whether the experimental drug Ampligen, which has helped many ME patients recover or improve, should be approved. Should the drug be approved, it will be an ME game-changer.

    Oddly, little has been discussed on the boards about Ampligen this time around—perhaps because the drug’s been up for approval several times before—and that’s too bad, because an approved drug would help legitimize the disease, provide much-needed treatment for patients, and signal to other drug companies that the disease is worthy of effective medications—and not psychobabble.

    Eighteen years ago, I wrote a piece on Ampligen for Philadelphia magazine called The AIDS Drug No One Can Have. Back then the drug proved remarkably helpful for both ME and HIV/AIDS. Many patients went from bedridden to returning to work and school and a few with ME whom I interviewed who’d been ill for only a few years completely recovered.

    Then the FDA insisted on a formula change to make the intravenous drug easier to administer; it’s not clear if the new formulation is as effective, but many patients have continued to report improvement.

    The FDA has tentatively scheduled the review process to begin December 20 and to continue to February 2.

    In the meantime, the FDA wants to hear from patients by November 1 about their experiences with ME, including how drugs like Ampligen have helped in treating the disease. The FDA is also interested in learning about the emblematic endpoints that should be used in reviewing ME drugs for approval. Fatigue, for instance, is a a subjective and often inaccurate marker with ME. Improvement in post-exertional malaise would be a far more significant marker.

    Patients can submit comments about Ampligen to the FDA directlyhere or send in comments and I'll post them on CFS Central and forward them to the FDA. Pressure needs to be placed on the government so that these agencies will be forced—kicking and screaming—to do the right thing by patients.

See more popular forum discussions.

Share This Page